MANGALAM DRUGS AND ORGANICS
|
The Current P/E Ratio of MANGALAM DRUGS AND ORGANICS is 17.11.
Share Price | ₹102.0 | Jan 13,2025 |
Market Cap | ₹161.1 Cr | |
Earnings-TTM | ₹9.4 Cr | TTM-Standalone Results |
Price/Earnings | 17.11x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MANGALAM DRUGS AND ORGANICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹161.1 Cr] as on Jan 13,2025
(/) Earnings [ ₹9.4 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 17.11x ]
Thus, for MANGALAM DRUGS AND ORGANICS , the investors are currently willing to pay 17.11 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MANGALAM DRUGS AND ORGANICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MANGALAM DRUGS AND ORGANICS over the last five years.
Historical PE (Price/Earnings) ratio chart of MANGALAM DRUGS AND ORGANICS
PE Ratio Performance Analysis for MANGALAM DRUGS AND ORGANICS
- MANGALAM DRUGS AND ORGANICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 28.33x.
- MANGALAM DRUGS AND ORGANICS 's operated at median p/e ratio of 5.82x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANGALAM DRUGS AND ORGANICS 's p/e ratio peaked in Mar2023 at 121.95x.
- MANGALAM DRUGS AND ORGANICS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does MANGALAM DRUGS AND ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MANGALAM DRUGS AND ORGANICS | 9.42 | 17.11 | 161.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 37.62 | 418,936.0 |
CIPLA LTD | 4,485.22 | 25.91 | 116,200.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.59 | 111,325.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.81 | 98,037.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 82.87 | 152,157.0 |
MANKIND PHARMA LTD | 2,124.86 | 50.30 | 106,880.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 60.83 | 109,617.0 |
LUPIN LTD | 2,651.94 | 37.06 | 98,275.2 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.75 | 67,480.4 |
ABBOTT INDIA LTD | 1,284.66 | 47.22 | 60,664.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MANGALAM DRUGS AND ORGANICS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.11x |
Max industry PE | 82.87x |
Median industry PE | 37.06x |
Average industry PE | 38.28x |
You may also like the below Video Courses